Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Mathurin

Showing results (261-270 of 286) with videos related to

Pageof 29
Sort By:
JHEP Reports : Innovation in Hepatology|July 24, 2024
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohortVictor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, et al.
Lancet (London, England)|December 10, 2019
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZobair M Younossi, Vlad Ratziu, Rohit Loomba, et al.
Nature Communications|September 10, 2022
Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosisMarie Bobowski-Gerard, Clémence Boulet, Francesco P Zummo, et al.
Journal of Viral Hepatitis|November 1, 2018
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohortSegolene Brichler, Pierre Nahon, Fabien Zoulim, et al.
Gastroenterology|July 22, 2018
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance ProgramsPierre Nahon, Richard Layese, Valérie Bourcier, et al.
Hepatology (Baltimore, Md.)|June 28, 2016
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)Nathalie Ganne-Carrié, Richard Layese, Valérie Bourcier, et al.
World Journal of Hepatology|January 14, 2021
Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virusAnaïs Brayette, Marie Essig, Paul Carrier, et al.
Hepatology (Baltimore, Md.)|February 14, 2015
Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)Jean-Claude Trinchet, Valérie Bourcier, Cendrine Chaffaut, et al.
Journal of Hepatology|July 3, 2020
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV statusEtienne Audureau, Fabrice Carrat, Richard Layese, et al.
Nature Communications|July 18, 2019
Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitisJosepmaria Argemi, Maria U Latasa, Stephen R Atkinson, et al.
Pageof 29

Showing results (261-270 of 286) with videos related to

Sort By:
Pageof 29
JHEP Reports : Innovation in Hepatology|July 24, 2024
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohortVictor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, et al.
Lancet (London, England)|December 10, 2019
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZobair M Younossi, Vlad Ratziu, Rohit Loomba, et al.
Nature Communications|September 10, 2022
Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosisMarie Bobowski-Gerard, Clémence Boulet, Francesco P Zummo, et al.
Journal of Viral Hepatitis|November 1, 2018
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohortSegolene Brichler, Pierre Nahon, Fabien Zoulim, et al.
Gastroenterology|July 22, 2018
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance ProgramsPierre Nahon, Richard Layese, Valérie Bourcier, et al.
Hepatology (Baltimore, Md.)|June 28, 2016
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)Nathalie Ganne-Carrié, Richard Layese, Valérie Bourcier, et al.
World Journal of Hepatology|January 14, 2021
Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virusAnaïs Brayette, Marie Essig, Paul Carrier, et al.
Hepatology (Baltimore, Md.)|February 14, 2015
Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)Jean-Claude Trinchet, Valérie Bourcier, Cendrine Chaffaut, et al.
Journal of Hepatology|July 3, 2020
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV statusEtienne Audureau, Fabrice Carrat, Richard Layese, et al.
Nature Communications|July 18, 2019
Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitisJosepmaria Argemi, Maria U Latasa, Stephen R Atkinson, et al.
Pageof 29